Clinical Trials Directory

Trials / Unknown

UnknownNCT04136080

The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
752 (estimated)
Sponsor
Fujian Provincial Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Background: The mean arterial pressure( MAP) is a key pressure index to improve tissue perfusion. At present, there are no surprising results of large-scale clinical studies on sublingual microcirculation. The changes of sublingual microcirculation were more severe in septic shock non-survivors than survivors. Purpose: This study is mean to increase the MAP in septic shock patients whether with chronic hypertension or not, so as to observe the change of the microcirculation and prognosis. Method: This is a single-center, randomized, prospective cohort study. Eligible patients will be allocated into chronic hypertension or denying chronic hypertension group. These patients will be treat with vasopressors to maintain MAP at 90±5 mmHg and 70±5 mmHg. Outcome: The 28-day all-cause mortality, the 90-day all-cause mortality, the 28-day without organ dysfunction days, the Changes of sublingual microcirculation, SOFA, APACHE-Ⅱ score Will be recorded.

Conditions

Interventions

TypeNameDescription
OTHERvasopressorscontrol the mean arterial pressure with vasopressors

Timeline

Start date
2019-12-01
Primary completion
2021-01-30
Completion
2021-11-30
First posted
2019-10-23
Last updated
2019-10-23

Source: ClinicalTrials.gov record NCT04136080. Inclusion in this directory is not an endorsement.